BIT - announcement R&D Tax Incentive Biotron Limited (ASX: BIT) is pleased to announce that is has received an R&D Tax Incentive refund of $753,026 for the 2018/19 financial year. The R&D Tax Incentive is an Australian Government program under which companies receive cash refunds for 43.5% of eligible expenditure on research and development. The incentive refund results from expenditure on Biotron's antiviral drug development programs. Biotron's Managing Director, Dr Michelle Miller commented: "Whilst Biotron is fully funded for its current activities, this R&D cash rebate will strengthen the Company's cash position and support commercialisation activities."
